Michael O. Idowu, MB is an expert in the field of Pathology. Michael O. Idowu, MB is a published doctor as well. He has 33 publications published. The latest was: A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688. He accepts Medicare payments and is listed with Medicare.gov.
National Provider Identifier [NPI] | 1962413310 |
Last Name Of The Provider | IDOWU |
First Name Of The Provider | MICHAEL |
View All |
![]() |
Dr. Sarah E. Gibson, MD
![]() |
![]() |
Dr. Sukru S. Demirci, MD
![]() |
![]() |
Dr. Adele O. Kraft, MD
![]() |
![]() |
Dr. Enrique Gerszten, MD
![]() ![]() |
![]() |
Dr. Yasmin I. Lutterbie, MD
![]() |
![]() |
Dr. David M. Capuzzi, MD
![]() |
![]() |
Dr. Andrea G. Jelinek, DO |
![]() |
Dr. Austin B. Wiles, MD
![]() |
![]() |
Dipti A. Surve, MB BS
![]() |